Validated RP-HPLC method for the assay of zalcitabine in drug substance, formulated products and human serum

Pharmazie

Volumn 59, Issue 8, 2004, Pages 604-607

  Uslu, B ^a   Savaser A ^b   Ozkan S A ^a   Özkan, Yalç ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DEFLAZACORT; ZALCITABINE;

ACCURACY; ARTICLE; DRUG DETERMINATION; DRUG ISOLATION; HUMAN; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SERUM; TABLET;

CALIBRATION; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; INDICATORS AND REAGENTS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE INHIBITORS; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS; ZALCITABINE;

EID: 4143084843     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Fan B, Steward JT (2001) Determination of zidovudine/zalcitabine/ nevirapine in human plasma by ion-pair HPLC. J Liq Chromatogr Rel Tech 24: 3017-3026.
2. Harker AJ, Evans GL, Hawley AE, Morris DM (1994) High-performance liquid chromatographic assay for 2′-deoxy-3′-thiacytidine in human serum. J Chromatogr B Biomed Appl 657: 227-232.
3. Kalin JR, Hill DL (1988) Determination of 2′,3′- dideoxyinosine and 2′,3′-dideoxycytidine in biological samples. J Chromatogr 431: 184-191.
4. Magnani M, Rossi L, Bianchi M, Cucchiarini L, Stocchi V (1989) Reversed-phase liquid chromatographic determination of 2′,3′- dideoxycytidine in human blood samples. J Chromatogr 491: 215-220.
5. Morris DM, Selinger K (1994) Determination of 2′-deoxy-3′- thiacytidine (3TC) in human urine by liquid chromatography: direct injection with column switching. J Pharm Biomed Anal 12: 255-264.
6. Özkan SA, Uslu B (2002) A rapid HPLC assay for the determination of lamivudine in pharmaceuticals and human serum. J Liq Chromatogr Rel Techn 25: 1447-1456,
7. Özkan Y, Savaşer A, Taş Ç, Uslu B, Özkan SA (2003) Drug dissolution studies and determination of deflazacort in pharmaceutical formulation and human serum samples by RP-HPLC. J Liq Chromatogr Rel Techn 26: 2141-2156.
8. th Ed. Published by Medical Economics Company Inc., Montvale, N.J, p. 2898.
9. Riley CM, Rosanske TW (1996) Development and validation of analytical methods, Elsevier Science Ltd, New York.
10. Savaşer A, Özkan C K, Özkan Y, Uslu B, Özkan SA (2003) Development and validation of a RP-HPLC method for the determination of valacyclovir in tablets and human serum and its application to the drug dissolution studies. J Liq Chromatogr Rel Techn 26: 1755-1767.
11. Simon VA, Thiam MD, Lipford LC (2001) Determination of serum levels of thirteen human immunodeficiency virus-suppressing drugs by high-performance liquid chromatography. J Chromatogr A 913: 447-453.
12. nd Ed. John Wiley and Sons Inc., New York.
13. Swartz ME, Krull I S (1997) Analytical method development and validation, Marcel Dekker, New York.
14. th Ed., Pharmaceutical Press, London, p. 664.
15. The United States Pharmacopoeia (2000), The USP 24rd Ed.; [CD-ROM], Easton, Rand Mc Nally, Tounton, M.A.
16. Uslu B, Özkan SA (2002) Determination of lamivudine and zidovudine in binary mixture using first derivative spectrophotometric, first derivative of the ratio spectra and HPLC-UV methods. Anal Chim Acta 466: 175-185.